| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | LUMENIS LTD | 245 | 0 | 0.00% | ||
| 2 | TRANSITION THERAPEUTICS INC | 70,273 | 148,000 | 0.01% | ||
| 3 | CONCERT PHARMACEUTICALS INCORPORATED | 15,858 | 236,000 | 0.02% | ||
| 4 | PERRIGO CO PLC | 273 | 246,000 | 0.02% | ||
| 5 | AURIS MED HLDG AG | 63,967 | 316,000 | 0.03% | ||
| 6 | ZOSANO PHARMA CORP | 62,300 | 452,000 | 0.04% | ||
| 7 | GALECTIN THERAPEUTICS INC COM | 205,000 | 560,000 | 0.05% | ||
| 8 | CARA THERAPEUTICS INC | 46,700 | 567,000 | 0.06% | ||
| 9 | SAPIENS INTL CORP N V SHS NEW | 56,420 | 586,000 | 0.06% | ||
| 10 | IMPAX LABORATORIES INC | 15,000 | 689,000 | 0.07% | ||
| 11 | GENVEC INC | 360,325 | 735,000 | 0.07% | ||
| 12 | IMMUNOMEDICS INCORPORATED | 245,000 | 995,000 | 0.10% | ||
| 13 | Nice Systems LTD Sponsored | 18,250 | 1,161,000 | 0.11% | ||
| 14 | V F CORP | 17,600 | 1,227,000 | 0.12% | ||
| 15 | BROADCOM CORP CL A | 24,894 | 1,282,000 | 0.13% | ||
| 16 | APTOSE BIOSCIENCES INC | 221,096 | 1,415,000 | 0.14% | ||
| 17 | EXELIXIS INC | 400,000 | 1,504,000 | 0.15% | ||
| 18 | TOWERS WATSON & CO | 12,807 | 1,611,000 | 0.16% | ||
| 19 | Former Charter Communication (Del 5/18/2016) | 10,065 | 1,724,000 | 0.17% | ||
| 20 | INOTEK PHARMACEUTICALS CORP | 380,000 | 1,862,000 | 0.18% | ||
| 21 | Aldeyra Therapeutics Inc | 265,000 | 2,056,000 | 0.20% | ||
| 22 | WABTEC CORP | 22,365 | 2,108,000 | 0.21% | ||
| 23 | PALATIN TECHNOLOGIES INC COM | 2,540,266 | 2,261,000 | 0.22% | ||
| 24 | SUMMIT THERAPEUTICS PLC | 205,200 | 2,280,000 | 0.22% | ||
| 25 | TETRAPHASE PHARMACEUTICALS INC COM | 49,500 | 2,348,000 | 0.23% | ||
| 26 | TOBIRA THERAPEUTICS INC | 137,622 | 2,374,000 | 0.23% | ||
| 27 | SNAP ON INC | 15,340 | 2,443,000 | 0.24% | ||
| 28 | ELLOMAY CAPITAL LIMITED | 246,697 | 2,518,000 | 0.25% | ||
| 29 | TREVENA INC | 410,000 | 2,567,000 | 0.25% | ||
| 30 | Otonomy Inc | 113,000 | 2,598,000 | 0.25% | ||
| 31 | SCYNEXIS INC | 313,000 | 2,751,000 | 0.27% | ||
| 32 | IONIS PHARMACEUTICAL | 48,000 | 2,762,000 | 0.27% | ||
| 33 | COLUCID PHARMACEUTICALS ORD | 317,250 | 2,824,000 | 0.28% | ||
| 34 | CYTOKINETICS INC | 422,250 | 2,838,000 | 0.28% | ||
| 35 | WIX COM LTD | 120,305 | 2,842,000 | 0.28% | ||
| 36 | Carbylan Therapeutics Inc. | 400,000 | 2,860,000 | 0.28% | ||
| 37 | MEDICINES CO | 1,000 | 2,861,000 | 0.28% | Call | |
| 38 | STARBUCKS CORP | 53,583 | 2,873,000 | 0.28% | ||
| 39 | PTC THERAPEUTICS INC | 600 | 2,888,000 | 0.28% | Call | |
| 40 | IMMUNE DESIGN CORP | 140,000 | 2,891,000 | 0.28% | ||
| 41 | APPLE INC | 23,223 | 2,913,000 | 0.29% | ||
| 42 | MIRATI THERAPEUTICS INC COM | 95,000 | 2,990,000 | 0.29% | ||
| 43 | Tekmira Pharmaceuticals Corp. | 255,000 | 3,024,000 | 0.30% | ||
| 44 | MELLANOX TECHNOLOGIES LTD | 62,850 | 3,054,000 | 0.30% | ||
| 45 | APPLIED GENETIC TECHNOL CORP | 200,124 | 3,070,000 | 0.30% | ||
| 46 | UNIQURE NV | 115,000 | 3,105,000 | 0.30% | ||
| 47 | FIVE PRIME THERAPEUTICS INC | 125,000 | 3,105,000 | 0.30% | ||
| 48 | VERIFONE SYS INC | 93,055 | 3,160,000 | 0.31% | ||
| 49 | ACCELERON PHARMA INC | 100,000 | 3,164,000 | 0.31% | ||
| 50 | PTC THERAPEUTICS INC | 66,500 | 3,201,000 | 0.31% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001178913-15-002526, filed 2015.08.06).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
